31181-89-2

Usage

Uses

Used in Pharmaceutical Synthesis:
5-CHLORO-2-FORMYLPYRIDINE is used as a key intermediate in the production of various pharmaceuticals, leveraging its unique chemical structure to facilitate the creation of new and effective medications.
Used in Agrochemical Production:
In the agrochemical industry, 5-CHLORO-2-FORMYLPYRIDINE serves as an essential component in the synthesis of compounds designed to protect crops and enhance agricultural productivity.
Used in Anti-Inflammatory Research:
5-CHLORO-2-FORMYLPYRIDINE is utilized in scientific research as a potential anti-inflammatory agent, with ongoing studies aimed at understanding its effects on reducing inflammation and related conditions.
Used in Anti-Cancer Drug Development:
5-CHLORO-2-FORMYLPYRIDINE is also employed in the development of anti-cancer drugs, where its potential to modulate cellular processes and inhibit tumor growth is being explored.
Used in Hazardous Material Management:
Given its classification as a flammable liquid, 5-CHLORO-2-FORMYLPYRIDINE is also a subject of interest in the field of hazardous material management, where its safe handling, storage, and disposal are critical for ensuring the safety of workers and the environment.

InChI:InChI=1/C6H4ClNO/c7-5-1-2-6(4-9)8-3-5/h1-4H

Upstream product

• 68-12-2 N,N-dimethyl-formamide 
• 244221-57-6 5-chloro-2-iodo-pyridine 
• 72093-07-3 2-methyl-5-chloropyridine 

Downstream Products

• 1190747-05-7 C₃₀H₃₄ClN₇O 
• 923949-15-9 (4S)-4-benzyl-3-[(2E)-3-(5-chloropyridin-2-yl)prop-2-enoyl]-1,3-oxazolidin-2-one 
• 89809-64-3 2-cyano-5-chloropyridine 

Relevant academic research and scientific papers

Synthesis of new Zn (II) complexes for photo decomposition of organic dye pollutants, industrial wastewater and photo-oxidation of methyl arenes under visible-light

Synthesis of new Schiff's base Zn-complexes for photo-oxidation of methyl arenes and xylenes are reported under visible light irradiation conditions. All the synthesized new ligands and Zn-complexes are thoroughly characterized with various spectral analyses and confirmed as 1:1 ratio of Zn and ligand with distorted octahedral structure. The bandgap energies of the ligands are higher than its Zn-complexes. These synthesized new Zn(II) complexes are used for the photo-fragmentation of organic dye pollutants, photodegradation of food industrial wastewater and oxidation of methyl arenes which are converted into its respective aldehydes with moderate yields under visible light irradiation. The photooxidation reaction dependency on the intensity of the visible light was also studied. With the increase in the dosage of photocatalyst, the methyl groups are oxidized to get aldehydes and mono acid products, which are also identified from LC-MS data. Finally, [Zn(PPMHT)Cl] is with better efficiency than [Zn(PTHMT)Cl] and [Zn(MIMHPT)Cl] for oxidation of methyl arenes is reported under visible-light-driven conditions.

Pyrazolopyrrolidine compounds

The invention relates to compounds of formula (I) as described herein, pharmaceutical preparations comprising such compounds, uses and methods of use for such compounds in the treatment of a disorder or a disease mediated by the activity of MDM2 and/or MDM4, and combinations comprising such compounds.

PIPERIDINOYL-PYRROLIDINE AND PIPERIDINOYL-PIPERIDINE COMPOUNDS

The present invention relates to a class of compounds of general formula (I) and the salts, hydrates, solvates, polymorphs and prodrugs wherein n, R6, R7 and R10 are as defined herein and especially to MCR4 agonist compounds of formula (I), to their use in medicine, particularly in the treatment of sexual dysfunction and obesity, to intermediates useful in their synthesis and to compositions containing them.

NEW COMPOUNDS

The present invention relates to new compounds of formula I, wherein P Q X1 X2 X3 X4 X5 R R1 R2 R3 R4R5 G M1 M2 M3 m and n are defined as in formula I, a process for their preparation and new intermediates prepared therein, pharmaceutical formulations containing said compounds and to the use of said compounds in therapy.